)
Following the India-US trade deal and tariff adjustments, investors are closely analyzing which sectors remain insulated from potential tariff risks. Experts suggest that IT and pharmaceutical sectors are relatively protected due to their service-driven and high-value export models. These industries operate on long-term global contracts, reducing direct exposure to tariff